Treatment Strategies for Esophageal Cancer

• Autores: Dylan R. Nieman, Jeffrey Peters
• Localización: Gastroenterology clinics of North America, ISSN 0889-8553, Vol. 42, Nº. 1, 2013 (Ejemplar dedicado a: Benign and Neoplastic Conditions of the Esophagus), págs. 187-197
• Idioma: inglés
• Texto completo no disponible (Saber más ...)
• Resumen

  • The treatment of esophageal cancer has evolved considerably in the past decade and depends largely on the extent of disease at the time of presentation. For disease confined to the esophageal mucosa, endoscopic therapy is replacing esophagectomy as the standard of care. For locoregional disease, neoadjuvant chemoradiation followed by esophagectomy is the best strategy for optimizing long-term survival. In the minority of patents who present with metastatic disease, the prognosis is poor. Palliative therapies available for these patients include chemotherapy, radiation, endoscopic therapies to ameliorate obstruction or bleeding